PCRX - Pacira BioSciences, Inc.

QQQ $ 598.50 $ -4.01 (-0.67 %)

DIA $ 463.08 $ 2.03 (0.44 %)

SPY $ 662.74 $ -0.81 (-0.12 %)

TLT $ 90.69 $ 0.29 (0.32 %)

GLD $ 382.95 $ 2.70 (0.71 %)

Previous Close

$ 22.73

Open

$ 22.16

Bid

$ 22.75 x 15

Ask

$ 26.62 x 4

Day's Range

$ 22.02 - $ 22.82

52 Week Range

$ 16.00 - $ 27.64

Volume

405,877

Average Volume

Market Cap

1.02B

Beta (5Y Monthly)

$ 0.95

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-27-2025	01-01-1970	10-K
4	11-06-2024	09-30-2024	10-Q
5	07-30-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-02-2023	06-30-2023	10-Q
10	05-03-2023	03-31-2023	10-Q
11	02-28-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-03-2022	06-30-2022	10-Q
14	05-04-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	08-03-2021	06-30-2021	10-Q
18	05-04-2021	03-31-2021	10-Q
19	03-01-2021	12-31-2020	10-K
20	10-30-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-21-2020	12-31-2019	10-K
24	11-08-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-02-2019	03-31-2019	10-Q
27	02-28-2019	12-31-2018	10-K
28	11-01-2018	09-30-2018	10-Q
29	08-02-2018	06-30-2018	10-Q
30	05-03-2018	03-31-2018	10-Q
31	02-28-2018	12-31-2017	10-K
32	11-08-2017	09-30-2017	10-Q
33	08-02-2017	06-30-2017	10-Q
34	05-04-2017	03-31-2017	10-Q
35	03-01-2017	12-31-2016	10-K
36	11-02-2016	09-30-2016	10-Q
37	08-04-2016	06-30-2016	10-Q
38	05-02-2016	03-31-2016	10-Q
39	02-25-2016	12-31-2015	10-K
40	10-27-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Pacira BioSciences Narrows FY2025 Sales Gu...
08/05/2025 20:02:06

Pacira BioSciences (NASDAQ:PCRX) narrows FY2025 sales outlook from $725.000 million-$765.000 million to $730.000 million-$750.0...

Pacira BioSciences Q2 Adj. EPS $0.74 Beats...
08/05/2025 20:01:14

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0...

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Insights Ahead: Pacira BioSciences's Quart...
08/04/2025 19:08:09

Pacira BioSciences Collaborates With Johns...
07/22/2025 12:03:23

Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient accessBRISBA...

Pacira Biosciences Announces Reorganizatio...
07/10/2025 11:39:01

Pacira BioSciences Announces Phase 1 Data ...
06/11/2025 12:11:44

-- PCRX-201 demonstrated sustained clinical efficacy with improvements in pain, stiffness, and function for up to three years –...

Pacira Biosciences: New Preliminary Data S...
05/15/2025 12:13:16

-- Early clinical data indicates that Pre-existing and treatment-induced anti-Ad5 neutralizing antibodies do not impact the saf...

Where Pacira BioSciences Stands With Analysts
05/09/2025 13:00:31

Needham Maintains Buy on Pacira BioScience...
05/09/2025 12:47:59

Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and lowers the price target from $32 to...

Pacira BioSciences Affirms FY2025 Sales Gu...
05/08/2025 20:01:45

Pacira BioSciences (NASDAQ:PCRX) affirms FY2025 sales outlook from $725.00 million-$765.00 million to $725.00 million-$765.00 m...

Pacira BioSciences Q1 Adj. EPS $0.62 Beats...
05/08/2025 20:01:13

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0...

Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

Preview: Pacira BioSciences's Earnings
05/07/2025 14:03:09

Pacira BioSciences Announces It Will Prese...
05/06/2025 12:03:06

Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies ...

Pacira BioSciences To Present Findings Fro...
05/02/2025 12:07:12

Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies ...

Pacira BioSciences Announces 2-Yr Data On ...
04/28/2025 12:05:40

- PCRX-201 demonstrated two years of clinically meaningful improvements in pain, stiffness and function across all structural s...

Pacira BioSciences To Present 104-Week Dat...
04/22/2025 20:02:13

-- Poster to be presented at OARSI World Congress on Osteoarthritis --

wolverine-world-wide-pacira-biosciences-and-other-big-stocks-moving-higher-on-monday

Wolverine World Wide, Pacira BioSciences A...
04/21/2025 14:36:15

Pacira BioSciences Announces $300M Share R...
04/17/2025 21:09:35